Open AccessEffectiveness of Universal School-Based Screening vs Targeted Screening for Major Depressive Disorder Among Adolescents
Author(s) -
Deepa L. Sekhar,
Krista L. Pattison,
Alexandra Confair,
Alissa Molinari,
Élise Schaefer,
James G. Waxmonsky,
Leslie R. Walker-Harding,
Perri Rosen,
Jennifer L. Kraschnewski
Publication year - 2019
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2019.14427
Subject(s) - referral , major depressive disorder , medicine , family medicine , randomized controlled trial , depression (economics) , mental health , patient health questionnaire , psychiatry , depressive symptoms , mood , anxiety , surgery , economics , macroeconomics
Key Points Question Is universal school-based screening for adolescent major depressive disorder (MDD) more effective than the existing process of targeted screening based on observable behaviors of concern? Findings Screening in High Schools to Identify, Evaluate, and Lower Depression (SHIELD) is a randomized clinical trial that will take place in at least 8 public senior high schools in Pennsylvania to evaluate the effectiveness of universal screening for identifying MDD and engaging students with resources. Meaning The SHIELD trial directly addresses the US Preventive Services Task Force call for large, high-quality randomized clinical trials to better understand the effects of MDD screening and quantify the proportion of adolescents with screen-detected MDD successfully referred and treated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom